Cargando…

Highest Obesity Category Associated With Largest Decrease in N‐Terminal Pro‐B‐Type Natriuretic Peptide in Patients Hospitalized With Heart Failure With Preserved Ejection Fraction

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) constitutes half of hospitalized heart failure cases and is commonly associated with obesity. The role of natriuretic peptide levels in hospitalized obese patients with HFpEF, however, is not well defined. We sought to evaluate chang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaishnav, Joban, Chasler, Jessica E., Lee, Yizhen J., Ndumele, Chiadi E., Hu, Jiun‐Ruey, Schulman, Steven P., Russell, Stuart D., Sharma, Kavita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792252/ https://www.ncbi.nlm.nih.gov/pubmed/32750299 http://dx.doi.org/10.1161/JAHA.119.015738

Ejemplares similares

Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction
por: Yang, Eunice, et al.
Publicado: (2022)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adults
por: Commodore-Mensah, Yvonne, et al.
Publicado: (2023)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

Patients with heart failure with preserved ejection fraction and low levels of natriuretic peptides
por: Meijers, W. C., et al.
Publicado: (2016)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

Categories of highest weight modules: applications to classical Hermitian symmetric pairs
por: Enright, Thomas J, et al.
Publicado: (1987)

Marked elevation of B-type natriuretic peptide in patients with heart failure and preserved ejection fraction
por: Tate, Samuel, et al.
Publicado: (2014)

Natriuretic Peptide Levels and Stages of Left Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction
por: Dal Canto, Elisa, et al.
Publicado: (2023)

HIV infection in Eastern and Southern Africa: Highest burden, largest challenges, greatest potential
por: Parker, Erica, et al.
Publicado: (2021)

N‐terminal pro‐B‐type natriuretic peptide testing patterns in patients with heart failure with reduced ejection fraction
por: Januzzi, James L., et al.
Publicado: (2021)

The world's second largest population of humpback dolphins in the waters of Zhanjiang deserves the highest conservation priority
por: Xu, Xinrong, et al.
Publicado: (2015)

Crossing the Bridge to Heart Transplantation: Biventricular Impella to Support an Unstable LVAD Patient
por: Vaishnav, Joban, et al.
Publicado: (2020)

Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
por: Tanase, Daniela Maria, et al.
Publicado: (2019)

Usefulness of B‐Type Natriuretic Peptide for Predicting the Risk of Stroke in Patients With Heart Failure With Preserved Ejection Fraction
por: Liu, Xiao, et al.
Publicado: (2022)

The largest amber-preserved flower revisited
por: Sadowski, Eva-Maria, et al.
Publicado: (2023)

Factors Associated With Elevated N-Terminal Pro B-Type Natriuretic Peptide Concentrations at the Convalescent Stage and 1-Year Outcomes in Patients With Heart Failure With Preserved Ejection Fraction
por: Oeun, Bolrathanak, et al.
Publicado: (2020)

Impact of Socioeconomic Status on Mortality and Readmission in Patients With Heart Failure With Reduced Ejection Fraction: The ARIC Study
por: Mathews, Lena, et al.
Publicado: (2022)

Natriuretic peptides for the detection of diastolic dysfunction and heart failure with preserved ejection fraction—a systematic review and meta-analysis
por: Remmelzwaal, Sharon, et al.
Publicado: (2020)

Role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Eroume-A Egom, Emmanuel, et al.
Publicado: (2020)

Respiratory support in acute heart failure with preserved vs reduced ejection fraction
por: Metkus, Thomas S., et al.
Publicado: (2019)

Activity in perirhinal and entorhinal cortex predicts perceived visual similarities among category exemplars with highest precision
por: Ferko, Kayla M, et al.
Publicado: (2022)

Pericardial Effusion in Postcoronavirus Disease Patients with Preserved Ejection Fraction of the Left Ventricle and Normal Values of N-Terminal-Pro B-Type Natriuretic Peptide-Link with C-Reactive Protein and D-Dimer
por: Begić, Edin, et al.
Publicado: (2022)

Authors’ reply: role of natriuretic peptide receptor C signalling in obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension
por: Agrawal, Vineet, et al.
Publicado: (2020)

Combined Assessment of D-Dimer with the Get with the Guidelines—Heart Failure Risk Score and N-Terminal Pro-B-Type Natriuretic Peptide in Patients with Acute Decompensated Heart Failure with Preserved and Reduced Ejection Fraction
por: Naruse, Hiroyuki, et al.
Publicado: (2021)

Incidence of components of Metabolic Syndrome in the metabolically healthy obese over 9 years follow-up: the Atherosclerosis Risk in Communities study
por: Bradshaw, Patrick T., et al.
Publicado: (2017)

Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients
por: Berezin, Alexander A., et al.
Publicado: (2022)

Body Mass Index, Natriuretic Peptides, and Risk of Adverse Outcomes in Patients With Heart Failure and Preserved Ejection Fraction: Analysis From the TOPCAT Trial
por: Pandey, Ambarish, et al.
Publicado: (2018)

Natriuresis, Diuresis, and Volume Changes in Diabetics With Heart Failure With Preserved Ejection Fraction: Impact of Sodium‐Glucose Cotransporter 2 Inhibitors on Natriuretic Peptides
por: Silva Enciso, J.
Publicado: (2020)

Disparities in the Use of Cardiac Rehabilitation in African Americans
por: Mathews, Lena, et al.
Publicado: (2022)

N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) study
por: Jones, Erika, et al.
Publicado: (2020)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF
por: Lewis, Gregory D., et al.
Publicado: (2023)

Multimodality Imaging in the Evaluation and Prognostication of Cardiac Amyloidosis
por: Scheel, Paul J., et al.
Publicado: (2022)

Strategies for management of heart failure with preserved ejection fraction
por: Winchester, David E.
Publicado: (2019)

Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
por: Tsentsiper, L, et al.
Publicado: (2015)

Multi-category classification of left ventricle ejection fraction using a convolutional neural network
por: Carter, R, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Association of N-terminal pro-B-type natriuretic peptide levels and mortality risk in acute myocardial infarction across body mass index categories: an observational cohort study
por: Wang, Man, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q3n8nf4votf6db6k6tpgds7fgg